Your session is about to expire
← Back to Search
Human Milk Fortification for Premature Infants
Study Summary
This trial is studying whether adding a fortifier to preterm human milk will improve outcomes for extremely premature babies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My infant has a severe birth defect like Down syndrome, heart issues, or abdominal wall problems.My baby was born at or before 27 weeks and admitted to the NICU within their first week.
- Group 1: Early Routine Fortification
- Group 2: Selective Fortification
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent is the patient base involved in this experiment?
"Affirmative, the data hosted on clinicaltrials.gov suggest that this research project is presently accruing individuals for participation. This endeavour, which was first uploaded to the website on February 15th 2020 and last updated August 3rd 2021, requires 200 participants from one distinct centre."
Am I qualified to participate in this experiment?
"This medical study is recruiting up to 200 infants with enterocolitis between 0 days and 6 days of age."
Are enrollment opportunities still available for this clinical trial?
"Affirmative. The clinicaltrial.gov listing reveals that this research, which was originally posted on February 15th 2020, is presently recruiting participants. 200 individuals need to be enlisted from one centre in total."
Is this clinical trial admitting geriatric individuals as participants?
"According to the criteria for inclusion in this medical trial, neonates aged 0-6 days qualify."
Share this study with friends
Copy Link
Messenger